{
    "Trade/Device Name(s)": [
        "FREND\u2122 Free T4 Test System",
        "FREND\u2122 Free T4 (reagent cartridge)",
        "FREND\u2122 System"
    ],
    "Submitter Information": "NanoEnTek, Inc.",
    "510(k) Number": "K152422",
    "Predicate Device Reference 510(k) Number(s)": [
        "K123379"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CEC"
    ],
    "Summary Letter Date": "December 31, 2015",
    "Summary Letter Received Date": "January 4, 2016",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1695"
    ],
    "Regulation Name(s)": [
        "Free thyroxine test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "Free thyroxine"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Lithium heparinized plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "FREND\u2122 System"
    ],
    "Method(s)/Technology(ies)": [
        "Fluorescence immunoassay",
        "Microfluidic lateral flow"
    ],
    "Methodologies": [
        "Competitive immunoassay"
    ],
    "Submission Type(s)": [
        "Test System",
        "Cartridge",
        "Reagent",
        "Code Chip"
    ],
    "Document Summary": "FDA 510(k) summary for NanoEnTek FREND\u2122 Free T4 Test System using fluorescence immunoassay to quantify free thyroxine in human serum and plasma",
    "Indications for Use Summary": "Quantitative determination of free thyroxine (Free T4) in human serum and lithium heparinized plasma for diagnosis of thyroid disorders in clinical laboratories; not intended for point-of-care facilities",
    "fda_folder": "Clinical Chemistry"
}